BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 17270319)

  • 1. Intranasal immunization with phosphorylcholine induces antigen specific mucosal and systemic immune responses in mice.
    Tanaka N; Fukuyama S; Fukuiwa T; Kawabata M; Sagara Y; Ito HO; Miwa Y; Nagatake T; Kiyono H; Kurono Y
    Vaccine; 2007 Mar; 25(14):2680-7. PubMed ID: 17270319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal and systemic immune response to sublingual or intranasal immunization with phosphorylcholine.
    Maseda Y; Ohori J; Tanaka N; Nagano H; Miyashita K; Kurono Y
    Auris Nasus Larynx; 2018 Apr; 45(2):273-280. PubMed ID: 28478921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal immune features to phosphorylcholine by nasal Flt3 ligand cDNA-based vaccination.
    Baatarjav T; Kataoka K; Gilbert RS; Terao Y; Fukui M; Goto M; Kawabata S; Yamamoto M; Fujihashi K; Ito HO
    Vaccine; 2011 Aug; 29(34):5747-57. PubMed ID: 21683111
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcutaneous immunization with phosphorylcholine induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
    Nagano H; Kurono Y
    Auris Nasus Larynx; 2015 Dec; 42(6):478-82. PubMed ID: 26092312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylcholine intranasal immunization with a 13-valent pneumococcal conjugate vaccine can boost immune response against Streptococcus pneumoniae.
    Ohori J; Iuchi H; Maseda Y; Kurono Y
    Vaccine; 2020 Jan; 38(3):699-704. PubMed ID: 31668823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization.
    Hotomi M; Ikeda Y; Suzumoto M; Yamauchi K; Green BA; Zlotnick G; Billal DS; Shimada J; Fujihara K; Yamanaka N
    Vaccine; 2005 Jan; 23(10):1294-300. PubMed ID: 15652672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nasal immunization induces Haemophilus influenzae-specific Th1 and Th2 responses with mucosal IgA and systemic IgG antibodies for protective immunity.
    Kurono Y; Yamamoto M; Fujihashi K; Kodama S; Suzuki M; Mogi G; McGhee JR; Kiyono H
    J Infect Dis; 1999 Jul; 180(1):122-32. PubMed ID: 10353870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcutaneous immunization in auricle skin induces antigen-specific mucosal and systemic immune responses in BALB/c mice.
    Nagano H; Jimura T; Nagano M; Makise T; Miyashita K; Kurono Y
    Auris Nasus Larynx; 2017 Aug; 44(4):411-416. PubMed ID: 27637556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mucosal immune system of the upper respiratory tract and recent progress in mucosal vaccines.
    Kurono Y
    Auris Nasus Larynx; 2022 Feb; 49(1):1-10. PubMed ID: 34304944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intranasal immunization with outer membrane protein P6 and cholera toxin induces specific sinus mucosal immunity and enhances sinus clearance of nontypeable Haemophilus influenzae.
    Sabirov A; Kodama S; Sabirova N; Mogi G; Suzuki M
    Vaccine; 2004 Aug; 22(23-24):3112-21. PubMed ID: 15297063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nasal vaccination with CpG oligodeoxynucleotide induces protective immunity against non-typeable Haemophilus influenzae in the nasopharynx.
    Abe N; Kodama S; Hirano T; Eto M; Suzuki M
    Laryngoscope; 2006 Mar; 116(3):407-12. PubMed ID: 16540899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific mucosal immunity and enhanced nasopharyngeal clearance of nontypeable Haemophilus influenzae after intranasal immunization with outer membrane protein P6 and cholera toxin.
    Hotomi M; Saito T; Yamanaka N
    Vaccine; 1998 Dec; 16(20):1950-6. PubMed ID: 9796049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of intranasal IL-12 to target predominantly Th1 responses to nasal and Th2 responses to oral vaccines given with cholera toxin.
    Marinaro M; Boyaka PN; Jackson RJ; Finkelman FD; Kiyono H; Jirillo E; McGhee JR
    J Immunol; 1999 Jan; 162(1):114-21. PubMed ID: 9886376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Th17 cells contribute to nontypeable Haemophilus influenzae-specific protective immunity induced by nasal vaccination with P6 outer membrane protein and α-galactosylceramide.
    Noda K; Kodama S; Umemoto S; Nomi N; Hirano T; Suzuki M
    Microbiol Immunol; 2011 Aug; 55(8):574-81. PubMed ID: 21605159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nasal immunization with plasmid DNA encoding P6 protein and immunostimulatory complexes elicits nontypeable Haemophilus influenzae-specific long-term mucosal immune responses in the nasopharynx.
    Kodama S; Hirano T; Noda K; Umemoto S; Suzuki M
    Vaccine; 2011 Feb; 29(10):1881-90. PubMed ID: 21237276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel phosphocholine antigen protects both normal and X-linked immune deficient mice against Streptococcus pneumoniae. Comparison of the 6-O-phosphocholine hydroxyhexanoate-conjugate with other phosphocholine-containing vaccines.
    Fischer RT; Longo DL; Kenny JJ
    J Immunol; 1995 Apr; 154(7):3373-82. PubMed ID: 7897220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intranasal immunization enhances clearance of nontypeable Haemophilus influenzae and reduces stimulation of tumor necrosis factor alpha production in the murine model of otitis media.
    Sabirov A; Kodama S; Hirano T; Suzuki M; Mogi G
    Infect Immun; 2001 May; 69(5):2964-71. PubMed ID: 11292713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of nasal colonization of nontypeable Haemophilus influenzae following intranasal immunization with rLP4/rLP6/UspA2 proteins combined with aqueous formulation of RC529.
    Mason KW; Zhu D; Scheuer CA; McMichael JC; Zlotnick GW; Green BA
    Vaccine; 2004 Sep; 22(25-26):3449-56. PubMed ID: 15308371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cell-targeting DNA-based nasal adjuvants for protective mucosal immunity to Streptococcus pneumoniae.
    Kataoka K; Fukuyama Y; Briles DE; Miyake T; Fujihashi K
    Microbiol Immunol; 2017 Jun; 61(6):195-205. PubMed ID: 28463465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intranasal immunization with phosphorylcholine suppresses allergic rhinitis in mice.
    Miyashita K; Ohori J; Nagano H; Fukuyama S; Kurono Y
    Laryngoscope; 2018 Jul; 128(7):E234-E240. PubMed ID: 29193138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.